1
|
Kim SM, Heo HR, Kim CS, Shin HH. Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents. Front Bioeng Biotechnol 2024; 12:1319830. [PMID: 38725991 PMCID: PMC11079243 DOI: 10.3389/fbioe.2024.1319830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 04/11/2024] [Indexed: 05/12/2024] Open
Abstract
Bacteriophages, also known as phages, are viruses that replicate in bacteria and archaea. Phages were initially discovered as antimicrobial agents, and they have been used as therapeutic agents for bacterial infection in a process known as "phage therapy." Recently, phages have been investigated as functional nanomaterials in a variety of areas, as they can function not only as therapeutic agents but also as biosensors and tissue regenerative materials. Phages are nontoxic to humans, and they possess self-assembled nanostructures and functional properties. Additionally, phages can be easily genetically modified to display specific peptides or to screen for functional peptides via phage display. Here, we demonstrated the application of phage nanomaterials in the context of tissue engineering, sensing, and probing.
Collapse
Affiliation(s)
- Seong-Min Kim
- Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
| | - Hye Ryoung Heo
- Department of Chemical and Biochemical Engineering, Dongguk University, Seoul, Republic of Korea
| | - Chang Sup Kim
- Department of Chemical and Biochemical Engineering, Dongguk University, Seoul, Republic of Korea
| | - Hwa Hui Shin
- Medical Device Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea
| |
Collapse
|
2
|
Jang WB, Yi D, Nguyen TM, Lee Y, Lee EJ, Choi J, Kim YH, Choi EJ, Oh JW, Kwon SM. Artificial Neural Processing-Driven Bioelectronic Nose for the Diagnosis of Diabetes and Its Complications. Adv Healthc Mater 2023; 12:e2300845. [PMID: 37449876 DOI: 10.1002/adhm.202300845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 07/10/2023] [Accepted: 07/11/2023] [Indexed: 07/18/2023]
Abstract
Diabetes and its complications affect the younger population and are associated with a high mortality rate; however, early diagnosis can contribute to the selection of appropriate treatment regimens that can reduce mortality. Although diabetes diagnosis via exhaled breath has great potential for early diagnosis, research on such diagnosis is restricted to disease detection, requiring in-depth examination to diagnose and classify diseases and their complications. This study demonstrates the use of an artificial neural processing-based bioelectronic nose to accurately diagnose diabetes and classify diabetic types (type I and II) and their complications, such as heart disease. Specifically, an M13 phage-based electronic nose (e-nose) is used to explore the features of subjects with diabetes at various levels of cellular and organismal organization (cells, liver organoids, and mice). Exhaled breath samples are collected during culturing and exposed to the phage-based e-nose. Compared with cells, liver organoids cultured under conditions mimicking a diabetic environment display properties that closely resemble the characteristics of diabetic mice. Using neural pattern separation, the M13 phage-based e-nose achieves a classification success rate of over 86% for four conditions in mice, namely, type 1 diabetes, type 2 diabetes, diabetic cardiomyopathy, and cardiomyopathy.
Collapse
Affiliation(s)
- Woong Bi Jang
- Laboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea
- Convergence Stem Cell Research Center, Pusan National University, Yangsan, 50612, Republic of Korea
| | - Dongwon Yi
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, 50612, Republic of Korea
| | - Thanh Mien Nguyen
- Bio-IT Fusion Technology Research Institute, Pusan National University, Busan, 46241, Republic of Korea
| | - Yujin Lee
- Department of Nano Fusion Technology, Pusan National University, Busan, 46214, Republic of Korea
| | - Eun Ji Lee
- Laboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea
- Convergence Stem Cell Research Center, Pusan National University, Yangsan, 50612, Republic of Korea
| | - Jaewoo Choi
- Laboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea
- Convergence Stem Cell Research Center, Pusan National University, Yangsan, 50612, Republic of Korea
| | - You Hwan Kim
- Department of Nano Fusion Technology, Pusan National University, Busan, 46214, Republic of Korea
| | - Eun-Jung Choi
- Department of Nano Fusion Technology, Pusan National University, Busan, 46214, Republic of Korea
| | - Jin-Woo Oh
- Bio-IT Fusion Technology Research Institute, Pusan National University, Busan, 46241, Republic of Korea
- Department of Nano Fusion Technology, Pusan National University, Busan, 46214, Republic of Korea
- Korea Nanobiotechnology Center, Pusan National University, Busan, 46241, Republic of Korea
| | - Sang-Mo Kwon
- Laboratory for Vascular Medicine and Stem Cell Biology, Department of Physiology, Medical Research Institute, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea
- Convergence Stem Cell Research Center, Pusan National University, Yangsan, 50612, Republic of Korea
| |
Collapse
|
3
|
Nguyen T, Chung JH, Bak GH, Kim YH, Kim M, Kim YJ, Kwon RJ, Choi EJ, Kim KH, Kim YS, Oh JW. Multiarray Biosensor for Diagnosing Lung Cancer Based on Gap Plasmonic Color Films. ACS Sens 2022; 8:167-175. [PMID: 36584356 PMCID: PMC9887647 DOI: 10.1021/acssensors.2c02001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Adaptable and sensitive materials are essential for the development of advanced sensor systems such as bio and chemical sensors. Biomaterials can be used to develop multifunctional biosensor applications using genetic engineering. In particular, a plasmonic sensor system using a coupled film nanostructure with tunable gap sizes is a potential candidate in optical sensors because of its simple fabrication, stability, extensive tuning range, and sensitivity to small changes. Although this system has shown a good ability to eliminate humidity as an interferant, its performance in real-world environments is limited by low selectivity. To overcome these issues, we demonstrated the rapid response of gap plasmonic color sensors by utilizing metal nanostructures combined with genetically engineered M13 bacteriophages to detect volatile organic compounds (VOCs) and diagnose lung cancer from breath samples. The M13 bacteriophage was chosen as a recognition element because the structural protein capsid can readily be modified to target the desired analyte. Consequently, the VOCs from various functional groups were distinguished by using a multiarray biosensor based on a gap plasmonic color film observed by hierarchical cluster analysis. Furthermore, the lung cancer breath samples collected from 70 healthy participants and 50 lung cancer patients were successfully classified with a high rate of over 89% through supporting machine learning analysis.
Collapse
Affiliation(s)
- Thanh
Mien Nguyen
- Bio-IT
Fusion Technology Research Institute, Pusan
National University, Busan 46241, Republic of Korea
| | - Jae Heun Chung
- Department
of Internal Medicine, College of Medicine, Pusan National University, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea
| | - Gyeong-Ha Bak
- Department
of Nano Fusion Technology, Pusan National
University, Busan 46241, Republic of Korea
| | - You Hwan Kim
- Department
of Nano Fusion Technology, Pusan National
University, Busan 46241, Republic of Korea
| | - Minjun Kim
- Department
of Physics, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Ye-Ji Kim
- Department
of Nano Fusion Technology, Pusan National
University, Busan 46241, Republic of Korea
| | - Ryuk Jun Kwon
- Family
Medicine Clinic and Research Institute of Convergence of Biomedical
Science and Technology, Pusan National University
Yangsan Hospital, Beomeo-ri, Mulgeum-eup, Yangsan, Gyeongsangnam-do 50612, Republic of Korea
| | - Eun-Jung Choi
- Bio-IT
Fusion Technology Research Institute, Pusan
National University, Busan 46241, Republic of Korea,Korea
Nanobiotechnology Center, Pusan National
University, Busan 46241, Republic of Korea
| | - Kwang Ho Kim
- School
of Materials Science and Engineering, Pusan
National University, Busan 46241, Republic of Korea,Global
Frontier Research and Development Center for Hybrid Interface Materials, Pusan National University, Busan 46241, Republic
of Korea,
| | - Yun Seong Kim
- Department
of Internal Medicine, College of Medicine, Pusan National University, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea,Research
Institute of Convergence Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea,
| | - Jin-Woo Oh
- Bio-IT
Fusion Technology Research Institute, Pusan
National University, Busan 46241, Republic of Korea,Department
of Nano Fusion Technology, Pusan National
University, Busan 46241, Republic of Korea,Department
of Nanoenergy Engineering and Research Center for Energy Convergence
Technology, Pusan National University, Busan 46241, Republic of Korea,Korea
Nanobiotechnology Center, Pusan National
University, Busan 46241, Republic of Korea,
| |
Collapse
|